Lumos Pharma Ownership | Who Owns Lumos Pharma?


OverviewForecastRevenueFinancialsChartTranscripts

Lumos Pharma Ownership Summary


Lumos Pharma is owned by 25.64% institutional investors, 32.69% insiders, and 41.67% retail investors. Wells fargo & company/mn is the largest institutional shareholder, holding 5.12% of LUMO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.17% of its assets in Lumos Pharma shares.

LUMO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLumos Pharma25.64%32.69%41.67%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wells fargo & company/mn414.98K5.12%$962.75K
Goldman sachs group406.61K5.02%$943.34K
Vanguard group244.08K3.01%$566.27K
Renaissance215.81K2.66%$500.69K
Jefferies financial group120.65K1.49%$279.91K
Lion point capital, lp90.79K1.12%$210.64K
Greenwich wealth management76.34K0.94%$177.00K
Geode capital management50.73K0.63%$117.71K
Blackrock41.10K0.51%$95.36K
Millennium management37.02K0.46%$85.88K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lion point capital, lp90.79K0.38%$210.64K
Wealth advisors of iowa11.70K0.02%$27.14K
Greenwich wealth management76.34K0.01%$177.00K
Paladin advisory group4.39K0.01%$9.93K
Key financial10.93K0.01%$25.35K
Jefferies financial group120.65K0.00%$279.91K
Bridgeway capital management27.64K0.00%$64.13K
Renaissance215.81K0.00%$500.69K
Private advisor group30.01K0.00%$69.63K
West financial advisors784.000.00%$1.82K

Top Buyers

HolderShares% AssetsChange
Private advisor group30.01K0.00%14.00K
Citadel advisors18.75K-5.46K
Envestnet asset management19.48K-3.36K
Geode capital management50.73K-3.13K
Tower research capital llc (trc)3.58K0.00%891.00

Top Sellers

HolderShares% AssetsChange
Acuitas investments---141.44K
Blackstone---78.62K
Two sigma advisers, lp---31.90K
Marquette asset management---25.76K
Two sigma investments, lp18.95K0.00%-19.87K

New Positions

HolderShares% AssetsChangeValue
Live oak investment partners11.00-11.00$26.00
Jones financial companies lllp4.00-4.00$9.00

Sold Out

HolderChange
Qube research-3.00
Global retirement partners-11.00
International assets investment management-38.00
Group one trading-150.00
Redwood wealth management group-500.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202435-2,077,959-4.52%253.55%1330.00%7-
Mar 31, 202435-5.41%2,176,429-8.07%263.05%10-9.09%740.00%
Dec 31, 20233712.12%2,367,466-3.00%293.32%1137.50%5-54.55%
Sep 30, 202333-2.94%2,440,6611.96%293.54%8-11.11%1183.33%
Jun 30, 202334-2,393,8107.21%293.96%9-10.00%650.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv187.32K2.17%-
Vanguard Institutional Extnd Mkt Idx Tr50.83K0.59%-
Fidelity Extended Market Index30.66K0.35%2.58K
Bridgeway Ultra-Small Company Market26.74K0.33%-
Fidelity Nasdaq Composite Index10.04K0.12%-
Fidelity Series Total Market Index7.10K0.08%1.73K
DFA US Targeted Value I6.64K0.08%-
Vanguard Instl Ttl Stck Mkt Idx Tr5.93K0.07%-
BlackRock Extended Equity Market K5.58K0.07%-2.00
Vanguard Instl Ttl Stk Mkt Idx InstlPls5.93K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 02, 2023McKew John C. Chief Scientific OfficerSell$10.92K
Apr 04, 2023McKew John C. Chief Scientific OfficerSell$7.24K
Feb 02, 2023McKew John C. Chief Scientific OfficerSell$1.55K
Nov 16, 2022McCracken Joseph S-Buy$20.12K
Sep 23, 2022Hawkins Richard J Chief Executive OfficerBuy$1.83K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q1--
2023 Q3-1
2023 Q2-1
2023 Q1-1

LUMO Ownership FAQ


Who Owns Lumos Pharma?

Lumos Pharma shareholders are primarily institutional investors at 25.64%, followed by 32.69% insiders and 41.67% retail investors. The average institutional ownership in Lumos Pharma's industry, Biotech Stocks , is 44.97%, which Lumos Pharma falls below.

Who owns the most shares of Lumos Pharma?

Lumos Pharma’s largest shareholders are Wells fargo & company/mn (414.98K shares, 5.12%), Goldman sachs group (406.61K shares, 5.02%), and Vanguard group (244.08K shares, 3.01%). Together, they hold 13.15% of Lumos Pharma’s total shares outstanding.

Does Blackrock own Lumos Pharma?

Yes, BlackRock owns 0.51% of Lumos Pharma, totaling 41.1K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 95.36K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Lumos Pharma’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Lumos Pharma’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 90.79K Lumos Pharma shares, valued at 210.64K$.

Who is the top mutual fund holder of Lumos Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lumos Pharma shares, with 2.17% of its total shares outstanding invested in 187.32K Lumos Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools